LONDON, Feb. 23, 2026 — Elsevier, a global leader in advanced information and decision support for science and healthcare, today announced a three-year integrated read-and-publish agreement with Jisc—the negotiating body for UK academic research institutions. The deal gives participating UK institutions continued access to Elsevier journals and enables eligible authors to publish open access in Elsevier titles.
Through Elsevier’s ongoing partnership with Jisc, the agreement supports UK academic research institutions by combining reading access with open access publishing choices, offering the following benefits to participating institutions:
- Ongoing access to Elsevier’s portfolio of peer-reviewed journals
- Open access publishing opportunities for eligible UK-affiliated corresponding authors
- Streamlined publishing workflows and reduced administrative load
- A collaborative, sector-led approach shaped by UK institutional needs
William Rubens, Regional Vice President, Research Sales at Elsevier, said: “We’re pleased to continue working with Jisc to support the UK’s world-class research community. At a time when institutions face multiple pressures, this agreement recognizes the importance of giving researchers clear paths to immediate open access—alongside continued access to high-quality, trusted research in Elsevier journals. Our partnership with Jisc is key to developing approaches that meet institutional needs and support the broader research community.”
Anna Vernon, Head of Research Licensing, Jisc, added: “This agreement underscores our commitment to the UK’s research community during a time of significant pressure. By bringing the sector together in these deals, we cut costs and ease administrative burdens for institutions and researchers. Our partnership with Elsevier is another step toward meeting evolving institutional needs and strengthening the UK’s open research landscape.”
Partnership for the Long Term
This agreement is part of Elsevier’s broader work with universities, funders, and sector organizations to advance open research and responsible publishing. Elsevier continues to collaborate with partners to evolve publishing models that meet the research community’s needs while preserving access to trusted scholarly content.
About Elsevier
Elsevier is a global leader in advanced information and decision support. For over a century, we’ve helped advance science and healthcare to drive human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals, and educators in 170 countries with their vital work. We do this by delivering mission-critical insights and innovative solutions that combine trusted, evidence-based scientific and medical content with cutting-edge AI technologies—helping those making an impact achieve better outcomes. We champion inclusion and sustainability by embedding these values into our products and culture, partnering with the communities we serve. Elsevier supports research and health partnerships around the world.
Elsevier is part of , a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit and follow us on social media @ElsevierConnect.
Logo –
SOURCE Elsevier Limited